title: Recombinant activated factor VII as an additional agent in the management of bleeding in patients with chemotherapy-induced thrombocytopenia.
authors.forename: Pavol
authors.initials: P
authors.lastname: Hollý
authors.forename: Lenka
authors.initials: L
authors.lastname: Lisá
authors.forename: Ivana
authors.initials: I
authors.lastname: Plameňová
authors.forename: Miroslava
authors.initials: M
authors.lastname: Dobrotová
authors.forename: Peter
authors.initials: P
authors.lastname: Kubisz
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects*; D015942:Factor VIIa / Q000008:administration & dosage*; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced / Q000188:drug therapy; D006801:Humans; D008232:Lymphoproliferative Disorders / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000008:administration & dosage; D013921:Thrombocytopenia / Q000139:chemically induced / Q000188:drug therapy
chemical_list: D011994:Recombinant Proteins; C103587:recombinant FVIIa; D015942:Factor VIIa